Skip to main content
Premium Trial:

Request an Annual Quote

Covance, ISB Partner on Brain Tumor Biology Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Contract research organization Covance today announced a collaboration between its genomics laboratory in Seattle and the Institute for Systems Biology to further research into brain tumor biology.

Specifically, Covance's expertise in genomics assays and ISB's expertise in complex genomic networks will be leveraged to unravel the regulation of gene expression in glioblastoma multiforme.

The partners will perform next-generation sequencing to generate datasets, which will be used by researchers to investigate tumor heterogeneity and to find targets for patient stratification and/or therapeutics, Covance said. The goal is to provide a high-quality map of gene expression and RNA structure to enable research into brain tumor biology, it added.

Financial and other terms of the deal were not disclosed.

"The ability to resolve complex regulatory networks requires reproducible, high-quality data," Lee Hood, president of ISB, said in a statement. "We know Covance's experience in genomics and next-generation sequencing will give us an unprecedented level of high-quality data."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.